Today, IHE releases a IHE report titled “Comparator report on patient access to cancer drugs in Europe – A UK perspective”. Major progress has been made in cancer care for the past 20 years but the report shows that the UK allocates less healthcare resources to cancer care, and generally has a slower uptake of new cancer drugs, than other Western European countries. The report, commissioned by the UK Pharmaceutical Industry Association, is presented today in London by oncologist Nils Wilking.
Read more